Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

​​Expanded coverage of pneumococcal 15-valent conjugate vaccine for Commercial members​

October 12, 2022

​Independence Blue Cross and Independence Administrators have expanded their coverage of the pneumococcal 15-valent conjugate vaccine for Commercial members.

Effective June 22, 2022, VaxneuvanceTM, a pneumococcal 15-valent conjugate vaccine, is considered medically necessary and, therefore, covered for individuals 6 weeks of age and older.

For more information, refer to the news article published on September 13, 2022.


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.